{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T10:23:44Z","timestamp":1786962224417,"version":"build-2736575974"},"reference-count":48,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.3201\/eid2509.180747","type":"journal-article","created":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T17:33:49Z","timestamp":1563903229000},"page":"1708-1718","source":"Crossref","is-referenced-by-count":57,"title":["Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000\u2013June 30, 2016"],"prefix":"10.3201","volume":"25","author":[{"given":"Godwin","family":"Oligbu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelmajid","family":"Djennad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen L.","family":"Sheppard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norman K.","family":"Fry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick J.","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ray","family":"Borrow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary E.","family":"Ramsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shamez N.","family":"Ladhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2509.180747-201908151438-R1","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1056\/NEJMoa1005384","article-title":"Bacterial meningitis in the United States, 1998-2007.","volume":"364","author":"Thigpen","year":"2011","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2509.180747-201908151438-R2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jinf.2007.07.009","article-title":"Morbidity and mortality of pneumococcal meningitis and serotypes of causative strains prior to introduction of the 7-valent conjugant pneumococcal vaccine in England.","volume":"55","author":"Johnson","year":"2007","journal-title":"J Infect"},{"key":"key-10.3201\/eid2509.180747-201908151438-R3","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1086\/514777","article-title":"A 20-year epidemiological study of pneumococcal meningitis.","volume":"28","author":"Stanek","year":"1999","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2509.180747-201908151438-R4","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/cid\/cix310","article-title":"Childhood deaths attributable to invasive pneumococcal disease in England and Wales, 2006\u20132014.","volume":"65","author":"Oligbu","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2509.180747-201908151438-R5","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1177\/000992280104001102","article-title":"Bacterial meningitis in childhood at the Children\u2019s Hospital of Pittsburgh: 1988-1998.","volume":"40","author":"Neuman","year":"2001","journal-title":"Clin Pediatr (Phila)"},{"key":"key-10.3201\/eid2509.180747-201908151438-R6","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1056\/NEJM199209173271208","article-title":"Bacterial meningitis: pathogenesis, pathophysiology, and progress.","volume":"327","author":"Quagliarello","year":"1992","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2509.180747-201908151438-R7","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jinf.2010.04.008","article-title":"The risk of sequelae due to pneumococcal meningitis in high-income countries: a systematic review and meta-analysis.","volume":"61","author":"Jit","year":"2010","journal-title":"J Infect"},{"key":"key-10.3201\/eid2509.180747-201908151438-R8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1172\/JCI12035","article-title":"Pneumococcal pneumolysin and H(2)O(2) mediate brain cell apoptosis during meningitis.","volume":"109","author":"Braun","year":"2002","journal-title":"J Clin Invest"},{"key":"key-10.3201\/eid2509.180747-201908151438-R9","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1172\/JCI30356","article-title":"TRAIL limits excessive host immune responses in bacterial meningitis.","volume":"117","author":"Hoffmann","year":"2007","journal-title":"J Clin Invest"},{"key":"key-10.3201\/eid2509.180747-201908151438-R10","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jinf.2009.12.008","article-title":"Epidemiology of invasive pneumococcal disease in the pre-conjugate vaccine era: England and Wales, 1996-2006.","volume":"60","author":"Trotter","year":"2010","journal-title":"J Infect"},{"key":"key-10.3201\/eid2509.180747-201908151438-R11","unstructured":"Salisbury D, Ramsay M, Noakes K, editors. Immunisation against infectious disease. The green book. Norwich, England: The Stationery Office; 2006 [cited 2018 May 3]. https:\/\/webarchive.nationalarchives.gov.uk\/20130104181824\/https:\/\/www.wp.dh.gov.uk\/immunisation\/files\/2012\/09\/Green-Book-updated-040113.pdf"},{"key":"key-10.3201\/eid2509.180747-201908151438-R12","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S1473-3099(15)70044-7","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.","volume":"15","author":"Waight","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2509.180747-201908151438-R13","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1016\/S1473-3099(11)70090-1","article-title":"Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study.","volume":"11","author":"Miller","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2509.180747-201908151438-R14","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1128\/JCM.01917-12","article-title":"Changes in molecular epidemiology of streptococcus pneumoniae causing meningitis following introduction of pneumococcal conjugate vaccination in England and Wales.","volume":"51","author":"Pichon","year":"2013","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2509.180747-201908151438-R15","doi-asserted-by":"publisher","first-page":"5477","DOI":"10.1016\/j.vaccine.2017.05.059","article-title":"Comparative incidence dynamics and serotypes of meningitis, bacteremic pneumonia and other-IPD in young children in the PCV era: Insights from Israeli surveillance studies.","volume":"36","author":"Ben-Shimol","year":"2018","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2509.180747-201908151438-R16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s12916-016-0755-7","article-title":"Impact of pneumococcal conjugate vaccines on pneumococcal meningitis cases in France between 2001 and 2014: a time series analysis.","volume":"14","author":"Alari","year":"2016","journal-title":"BMC Med"},{"key":"key-10.3201\/eid2509.180747-201908151438-R17","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1056\/NEJMoa0800836","article-title":"Effect of pneumococcal conjugate vaccine on pneumococcal meningitis.","volume":"360","author":"Hsu","year":"2009","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2509.180747-201908151438-R18","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1016\/j.vaccine.2017.06.070","article-title":"Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children.","volume":"35","author":"Ruiz-Contreras","year":"2017","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2509.180747-201908151438-R19","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1086\/587897","article-title":"Changing epidemiology of pneumococcal meningitis after the introduction of pneumococcal conjugate vaccine in the United States.","volume":"46","author":"Tsai","year":"2008","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2509.180747-201908151438-R20","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/cid\/civ368","article-title":"Impact of the 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in US children.","volume":"61","author":"Olarte","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2509.180747-201908151438-R21","doi-asserted-by":"publisher","first-page":"2882","DOI":"10.1016\/j.vaccine.2017.04.032","article-title":"Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literature.","volume":"35","author":"Tsaban","year":"2017","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2509.180747-201908151438-R22","doi-asserted-by":"publisher","first-page":"4543","DOI":"10.1016\/j.vaccine.2016.07.038","article-title":"Impact of PCV7\/PCV13 introduction on invasive pneumococcal disease (IPD) in young children: Comparison between meningitis and non-meningitis IPD.","volume":"34","author":"Ben-Shimol","year":"2016","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2509.180747-201908151438-R23","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1111\/j.1651-2227.2010.01914.x","article-title":"Rebound in the incidence of pneumococcal meningitis in northern France: effect of serotype replacement.","volume":"99","author":"Alexandre","year":"2010","journal-title":"Acta Paediatr"},{"key":"key-10.3201\/eid2509.180747-201908151438-R24","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/21645515.2015.1116654","article-title":"The multifaceted impact of pneumococcal conjugate vaccine implementation in children in France between 2001 to 2014.","volume":"12","author":"Cohen","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"key-10.3201\/eid2509.180747-201908151438-R25","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12879-015-0787-1","article-title":"Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in Germany.","volume":"15","author":"Im\u00f6hl","year":"2015","journal-title":"BMC Infect Dis"},{"key":"key-10.3201\/eid2509.180747-201908151438-R26","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1097\/INF.0000000000000267","article-title":"Trends in asymptomatic nasopharyngeal colonization with streptococcus pneumoniae after introduction of the 13-valent pneumococcal conjugate vaccine in Calgary, Canada.","volume":"33","author":"Ricketson","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.3201\/eid2509.180747-201908151438-R27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/21645515.2016.1263409","article-title":"A reflection on invasive pneumococcal disease and pneumococcal conjugate vaccination coverage in children in Southern Europe (2009-2016).","volume":"13","author":"Moreira","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"key-10.3201\/eid2509.180747-201908151438-R28","doi-asserted-by":"publisher","first-page":"e0166736","DOI":"10.1371\/journal.pone.0166736","article-title":"Impact and effectiveness of 10 and 13-valent pneumococcal conjugate vaccines on hospitalization and mortality in children aged less than 5 years in Latin American countries: a systematic review.","volume":"11","author":"de Oliveira","year":"2016","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2509.180747-201908151438-R29","doi-asserted-by":"publisher","first-page":"e015080","DOI":"10.1136\/bmjopen-2016-015080","article-title":"Bacterial meningitis in Finland, 1995-2014: a population-based observational study.","volume":"7","author":"Polkowska","year":"2017","journal-title":"BMJ Open"},{"key":"key-10.3201\/eid2509.180747-201908151438-R30","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jiac.2017.02.014","article-title":"Pediatric bacterial meningitis in Japan, 2013-2015 - 3-5 years after the wide use of Haemophilus influenzae type b and Streptococcus pneumoniae conjugated vaccines.","volume":"23","author":"Shinjoh","year":"2017","journal-title":"J Infect Chemother"},{"key":"key-10.3201\/eid2509.180747-201908151438-R31","doi-asserted-by":"publisher","first-page":"6160","DOI":"10.1016\/j.vaccine.2017.09.050","article-title":"Trends in pneumococcal meningitis hospitalizations following the introduction of the 13-valent pneumococcal conjugate vaccine in the United States.","volume":"35","author":"Jacobs","year":"2017","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2509.180747-201908151438-R32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1086\/648593","article-title":"Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.","volume":"201","author":"Pilishvili","year":"2010","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid2509.180747-201908151438-R33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1179\/acb.2003.58.1.003","article-title":"Antibiotic susceptibility and serotype distribution of 240 Streptococcus pneumoniae causing meningitis in Belgium 1997-2000.","volume":"58","author":"Verhaegen","year":"2003","journal-title":"Acta Clin Belg"},{"key":"key-10.3201\/eid2509.180747-201908151438-R34","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2223\/JPED.1580","article-title":"Streptococcus pneumoniae: a study of strains isolated from cerebrospinal fluid.","volume":"83","author":"Vieira","year":"2007","journal-title":"J Pediatr (Rio J)"},{"key":"key-10.3201\/eid2509.180747-201908151438-R35","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ijmm.2009.05.005","article-title":"Regional differences in serotype distribution, pneumococcal vaccine coverage, and antimicrobial resistance of invasive pneumococcal disease among German federal states.","volume":"300","author":"Im\u00f6hl","year":"2010","journal-title":"Int J Med Microbiol"},{"key":"key-10.3201\/eid2509.180747-201908151438-R36","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3201\/eid1907.121830","article-title":"Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011(1.).","volume":"19","author":"Richter","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2509.180747-201908151438-R37","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.3201\/eid1609.100102","article-title":"Pediatric pneumococcal serotypes in 4 European countries.","volume":"16","author":"Hanquet","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2509.180747-201908151438-R38","doi-asserted-by":"publisher","first-page":"ofw020","DOI":"10.1093\/ofid\/ofw020","article-title":"Insight into resistance phenotypes of emergent non 13-valent pneumococcal conjugate vaccine type pneumococci isolated from invasive disease after 13-valent pneumococcal conjugate vaccine implementation in France","volume":"3","author":"Janoir","year":"2016","journal-title":"Open Forum Infect Dis"},{"key":"key-10.3201\/eid2509.180747-201908151438-R39","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1128\/JCM.01547-08","article-title":"Population snapshot of Streptococcus pneumoniae serotype 19A isolates before and after introduction of seven-valent pneumococcal Vaccination for French children.","volume":"47","author":"Mahjoub-Messai","year":"2009","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid2509.180747-201908151438-R40","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/INF.0b013e318187e215","article-title":"Association of serotype of Streptococcus pneumoniae with risk of severe and fatal outcome.","volume":"28","author":"R\u00fcckinger","year":"2009","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.3201\/eid2509.180747-201908151438-R41","doi-asserted-by":"publisher","first-page":"e0177113","DOI":"10.1371\/journal.pone.0177113","article-title":"Serotype distribution of Streptococcus pneumoniae causing invasive disease in children in the post-PCV era: A systematic review and meta-analysis.","volume":"12","author":"Balsells","year":"2017","journal-title":"PLoS One"},{"key":"key-10.3201\/eid2509.180747-201908151438-R42","doi-asserted-by":"publisher","first-page":"6178","DOI":"10.1016\/j.vaccine.2015.10.015","article-title":"Invasive disease potential of pneumococci before and after the 13-valent pneumococcal conjugate vaccine implementation in children.","volume":"33","author":"Varon","year":"2015","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2509.180747-201908151438-R43","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1093\/cid\/civ692","article-title":"Effect of the 13-valent pneumococcal conjugate vaccine on pneumococcal meningitis in children.","volume":"62","author":"Levy","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key-10.3201\/eid2509.180747-201908151438-R44","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1097\/INF.0000000000001709","article-title":"Changes in the nature and severity of invasive pneumococcal disease in children before and after the seven-valent and thirteen-valent pneumococcal conjugate vaccine programs in Calgary, Canada.","volume":"37","author":"Ricketson","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"key-10.3201\/eid2509.180747-201908151438-R45","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3201\/eid1901.120741","article-title":"Invasive pneumococcal disease after routine pneumococcal conjugate vaccination in children, England and Wales.","volume":"19","author":"Ladhani","year":"2013","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid2509.180747-201908151438-R46","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jped.2014.07.002","article-title":"Pneumococcal meningitis: epidemiological profile pre- and post-introduction of the pneumococcal 10-valent conjugate vaccine.","volume":"91","author":"Hirose","year":"2015","journal-title":"J Pediatr (Rio J)"},{"key":"key-10.3201\/eid2509.180747-201908151438-R47","doi-asserted-by":"publisher","first-page":"c4704","DOI":"10.1136\/bmj.c4704","article-title":"NICE on bacterial meningitis. Vancomycin may not be necessary.","volume":"341","author":"Henderson","year":"2010","journal-title":"BMJ"},{"key":"key-10.3201\/eid2509.180747-201908151438-R48","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/jac\/dkp442","article-title":"Reduction in erythromycin resistance in invasive pneumococci from young children in England and Wales.","volume":"65","author":"Henderson","year":"2010","journal-title":"J Antimicrob Chemother"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/25\/9\/18-0747_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T17:29:55Z","timestamp":1732987795000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/25\/9\/18-0747_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2509.180747","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]}}}